LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator.
AstraZeneca's COVID-19 vaccine was first given the nod by the EMA in January 2021. Within weeks, however, concerns grew about the vaccine's safety, when dozens of countries suspended the vaccine's use after unusual but rare blood clots were detected in a small number of immunized people. The EU regulator concluded AstraZeneca's shot didn't raise the overall risk of clots, but doubts remained.
این خبر را خلاصه کرده ایم تا بتوانید سریع آن را بخوانید. اگر به خبر علاقه مند هستید، می توانید متن کامل را اینجا بخوانید. ادامه مطلب:
ایران آخرین اخبار, ایران سرفصلها
Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.
European Medicines Agency pulls authorization for AstraZeneca’s COVID-19 shot, at company’s requestAstraZeneca’s COVID-19 vaccine was first given the nod by the EMA in January 2021. Within weeks, however, concerns grew about the vaccine’s safety
منبع: globeandmail - 🏆 5. / 92 ادامه مطلب »
European Medicines Agency pulls authorization for AstraZeneca's COVID shot, at company's requestLONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator.
منبع: timescolonist - 🏆 15. / 75 ادامه مطلب »
AstraZeneca pulls its COVID vaccine from European marketLONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator.
منبع: timescolonist - 🏆 15. / 75 ادامه مطلب »
AstraZeneca pulls its COVID-19 vaccine from the European marketLONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines...
منبع: YahooFinanceCA - 🏆 47. / 63 ادامه مطلب »